stocks logo

RVPH Financial Analysis

Reviva Pharmaceuticals Holdings, Inc.
$
0.600
+0.070(+13.210%)

RVPH Financial Analysis

FY2024Q3FY2024Q2FY2024Q1FY2023Q4FY2023Q3FY2023Q2FY2023Q1FY2022Q4FY2022Q3FY2022Q2FY2022Q1FY2021Q4FY2021Q3FY2021Q2FY2021Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1FY2020Q4FY2020Q3FY2020Q2FY2020Q1
Total Revenue
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Revenue from Goods & Services
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling General & Administrative Expenses
8.46M
-26.82%
8.13M
-28.28%
7.92M
13.42%
9.99M
-14.60%
11.56M
224.56%
11.34M
105.37%
6.98M
-6.25%
11.70M
195.01%
3.56M
43.85%
5.52M
208.33%
7.45M
297.95%
3.96M
62.84%
2.48M
1.79M
1.87M
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Research & Development Expense
6.86M
-28.35%
5.58M
-32.36%
5.78M
5.47%
8.48M
-17.06%
9.57M
315.10%
8.26M
82.89%
5.48M
-5.93%
10.22M
283.80%
2.31M
62.01%
4.51M
1105.99%
5.83M
1390.44%
2.66M
802.17%
1.42M
374.33K
391.16K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Operating Expense - Net
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
0.00
-100.00%
393.47K
166.02K
94.11K
71.14K
393.47K
166.02K
94.11K
71.14K
Operating Profit
-8.46M
-26.82%
-8.13M
-28.28%
-7.92M
13.42%
-9.99M
-14.60%
-11.56M
224.56%
-11.34M
105.37%
-6.98M
-6.25%
-11.70M
195.01%
-3.56M
43.85%
-5.52M
208.33%
-7.45M
297.95%
-3.96M
206.91%
-2.48M
603.63%
-1.79M
240.37%
-1.87M
606.62%
-393.47K
-166.02K
-94.11K
-71.14K
-393.47K
-166.02K
-94.11K
-71.14K
Financing Income- Net
48.10K
-43.98%
82.46K
-8.71%
169.61K
21.71%
192.74K
53.16%
85.86K
73.43%
90.32K
1075.44%
139.36K
-60167.24%
125.84K
8103.46%
49.51K
-9151.01%
7.68K
-316.51%
-232.00
-256.76%
1.53K
-100.10%
-547.00
-114.39%
-3.55K
-135.88%
148.00
-99.86%
261.82K
302.83K
368.43K
409.56K
261.82K
302.83K
368.43K
409.56K
Interest Expense
-48.10K
-43.98%
-82.46K
-8.71%
-169.61K
21.71%
-192.74K
53.16%
-85.86K
73.43%
-90.32K
1075.44%
-139.36K
-60167.24%
-125.84K
8103.46%
-49.51K
-9151.01%
-7.68K
-316.51%
232.00
-256.76%
-1.53K
-100.10%
547.00
-114.39%
3.55K
-135.88%
-148.00
-99.86%
-249.75K
-323.70K
-351.74K
-398.75K
-249.75K
-323.70K
-351.74K
-398.75K
Non-Interest Financial Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.08K
-20.87K
16.69K
10.82K
12.08K
-20.87K
16.69K
10.82K
Other Non-Operating Income
-23.69K
-556.05%
-5.62K
29484.21%
-129.89K
796.19%
0.00
5.19K
-19.00
-14.49K
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Income before Taxes
-8.37M
-26.19%
-7.85M
-32.89%
-7.43M
8.43%
-9.73M
-19.14%
-11.33M
222.58%
-11.70M
119.38%
-6.85M
-6.96%
-12.03M
226.52%
-3.51M
54.29%
-5.33M
232.43%
-7.36M
676.11%
-3.68M
33.39%
-2.28M
553.95%
-1.60M
210.93%
-948.50K
508.93%
-131.65K
136.81K
274.32K
338.43K
-131.65K
136.81K
274.32K
338.43K
Income Taxes
0.00
-100.00%
7.39K
14.75%
7.40K
148.35%
-4.58K
-154.79%
12.12K
550.05%
6.44K
-7.01%
2.98K
-17.94%
8.36K
1.86K
-11.32%
6.92K
77.37%
3.63K
353.62%
0.00
-100.00%
2.10K
3.90K
800.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Income after Tax
-8.37M
-26.27%
-7.86M
-32.87%
-7.43M
8.49%
-9.72M
-19.24%
-11.35M
222.76%
-11.71M
119.22%
-6.85M
-6.97%
-12.04M
226.75%
-3.52M
54.23%
-5.34M
232.05%
-7.37M
675.84%
-3.68M
33.35%
-2.28M
554.56%
-1.61M
211.69%
-949.30K
509.44%
-131.65K
136.81K
274.32K
338.43K
-131.65K
136.81K
274.32K
338.43K
Income Available to Common Shares
-8.37M
-26.27%
-7.86M
-32.87%
-7.43M
8.49%
-9.72M
-19.24%
-11.35M
222.76%
-11.71M
119.22%
-6.85M
-6.97%
-12.04M
226.75%
-3.52M
54.23%
-5.34M
232.05%
-7.37M
675.84%
-3.68M
33.35%
-2.28M
554.56%
-1.61M
211.69%
-949.30K
509.44%
-131.65K
136.81K
274.32K
338.43K
-131.65K
136.81K
274.32K
338.43K
EPS - Basic
-0.25
-47.92%
-0.26
-50.00%
-0.25
-19.35%
-0.36
-34.55%
-0.48
242.86%
-0.52
48.57%
-0.31
-36.73%
-0.55
120.00%
-0.14
16.67%
-0.35
191.67%
-0.49
390.00%
-0.25
-63.77%
-0.12
-0.00%
-0.12
-36.84%
-0.10
66.67%
-0.05
0.05
0.11
0.13
-0.05
0.05
0.11
0.13
EPS - Diluted
-0.25
-47.92%
-0.26
-50.00%
-0.25
-19.35%
-0.36
-34.55%
-0.48
242.86%
-0.52
48.57%
-0.31
-36.73%
-0.55
120.00%
-0.14
16.67%
-0.35
191.67%
-0.49
390.00%
-0.25
-63.77%
-0.12
-0.00%
-0.12
-36.84%
-0.10
66.67%
-0.05
0.05
0.11
0.13
-0.05
0.05
0.11
0.13
EBIT
-8.46M
-26.82%
-8.13M
-28.28%
-7.92M
13.42%
-9.99M
-14.60%
-11.56M
224.56%
-11.34M
105.37%
-6.98M
-6.25%
-11.70M
195.01%
-3.56M
43.85%
-5.52M
208.33%
-7.45M
297.95%
-3.96M
206.91%
-2.48M
603.63%
-1.79M
240.37%
-1.87M
606.62%
-393.47K
-166.02K
-94.11K
-71.14K
-393.47K
-166.02K
-94.11K
-71.14K
EBITDA
-8.46M
-26.82%
-8.13M
-28.28%
-7.92M
13.42%
-9.99M
-14.60%
-11.56M
224.56%
-11.34M
105.37%
-6.98M
-6.25%
-11.70M
195.01%
-3.56M
43.85%
-5.52M
208.33%
-7.45M
297.95%
-3.96M
207.05%
-2.48M
603.63%
-1.79M
240.37%
-1.87M
606.62%
-393.47K
-166.02K
-94.11K
-71.14K
-393.47K
-166.02K
-94.11K
-71.14K
Depreciation Depletion & Amortization
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-100.00%
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

RVPH FAQs

What is RVPH's PE Ratio in 2025/4/4?

RVPH's PE ratio in April 4, 2025 is -0.59. This indicates the price investors are willing to pay for $1 of earnings.

What is RVPH's PS Ratio in 2025/4/4?

What is RVPH's Dividend Yield in 2024/Q4?

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

Is RVPH earnings result positive or negative?How should I trade on RVPH earnings?